| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/04/2003 | US6528647 Process for the synthesis of an aliphatic cyclic amine |
| 03/04/2003 | US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea |
| 03/04/2003 | US6528533 Treating or preventing neuronal damage associated with neurological diseases; hydrazide based compounds containing the group -N-N-CO-X- where X is C,O,S,or N |
| 03/04/2003 | US6528532 Benzenesulfonamide group |
| 03/04/2003 | US6528529 Compounds with activity on muscarinic receptors |
| 03/04/2003 | US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 03/04/2003 | US6528525 Amidocarboxylic acid derivatives |
| 03/04/2003 | US6528510 HIV protease inhibitors |
| 02/27/2003 | WO2003016318A1 Tumour inhibiting lanthane compounds |
| 02/27/2003 | WO2003016317A1 Processes for preparing calcium salt forms of statins |
| 02/27/2003 | WO2003016300A1 Ortho-substituted aryl amides for controlling invertebrate pests |
| 02/27/2003 | WO2003016288A1 Fxr nr1h4 nuclear receptor binding compounds |
| 02/27/2003 | WO2003016283A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use |
| 02/27/2003 | WO2003016282A2 Substituted 1h-dihydropyrazoles, their preparation and use |
| 02/27/2003 | WO2003016280A1 Nr1h4 nuclear receptor binding compounds |
| 02/27/2003 | WO2003016279A1 Fused-polycyclic compounds |
| 02/27/2003 | WO2003016267A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 02/27/2003 | WO2003016266A1 β-KETOAMIDE COMPOUNDS AND MEDICINAL USE THEREOF |
| 02/27/2003 | WO2003016265A1 Cyclic compound and ppar agonist |
| 02/27/2003 | WO2003015774A1 Compounds effecting glucokinase |
| 02/27/2003 | WO2003015519A1 Arthropodicidal anthranilamides |
| 02/27/2003 | WO2003015518A1 Method for controlling particular insect pests by applying anthranilamide compounds |
| 02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/27/2003 | WO2002090325A3 Benzazepinone alpha v integrin receptor antagonists |
| 02/27/2003 | WO2002089745A3 Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/27/2003 | WO2002088289A3 Use of metal complex compounds as oxidation catalysts |
| 02/27/2003 | WO2002072869A3 Novel agents for replacement of nad+/nadh system in enzymatic ractions |
| 02/27/2003 | WO2002066420A3 Tryptase inhibitors |
| 02/27/2003 | WO2002057422A3 Ternary biomolecule/polymer/surface-based immobilization systems |
| 02/27/2003 | US20030040629 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes |
| 02/27/2003 | US20030040545 (R)-Chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/27/2003 | US20030040483 Compounds with growth hormone releasing properties |
| 02/27/2003 | US20030040437 Substituted pyridine herbicides |
| 02/27/2003 | CA2456551A1 Tumour inhibiting lanthanum compounds |
| 02/27/2003 | CA2454298A1 Substituted 1h-dihydropyrazoles, their preparation and use |
| 02/26/2003 | EP1285947A1 Antimicrobial composition |
| 02/26/2003 | EP1285914A1 Nr1h4 nuclear receptor binding compounds |
| 02/26/2003 | EP1285913A1 Process for the preparation of 3,5-dichloropyridine |
| 02/26/2003 | EP1285902A1 Method for labeling with tritium |
| 02/26/2003 | EP1285656A1 Acetylcholinesterase inhibitors containing 1-benzyl- pyridinium salts |
| 02/26/2003 | EP1284961A1 Glycinamides |
| 02/26/2003 | EP1284956A1 Il-8 receptor antagonists |
| 02/26/2003 | EP1284739A1 Composition and method for intervening neuronal death using sulfasalazine |
| 02/26/2003 | EP1284733A1 Novel processes for preparing torsemide intermediate |
| 02/26/2003 | EP0885187B1 Diphenylethers, process and intermediate products for their preparation, and their use |
| 02/26/2003 | EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals |
| 02/26/2003 | CN1399629A Method for producing hydroxymethylpyridines |
| 02/26/2003 | CN1399627A Method of preparing substituted tetracyclines with transition metal-based chemistries |
| 02/26/2003 | CN1399550A Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
| 02/26/2003 | CN1399546A Injectable preparation for controlling fish live comprising benzoyl urea derivatives |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525210 Binaphthyl phospholanes, chelating phosphines and ferrocene complexes thereof |
| 02/25/2003 | US6525099 N-substituted sulfonamide derivatives |
| 02/25/2003 | US6525082 Apoptosis inducer |
| 02/25/2003 | US6525078 4-Methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinyl-methyl)-1,3-benzenedicarboxamide; vascular diseases |
| 02/25/2003 | US6525077 Cyanoguanidine prodrugs |
| 02/25/2003 | US6525067 Substituted heterocyclic derivatives |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/25/2003 | US6525020 For drug delivery |
| 02/21/2003 | WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/21/2003 | WO2002016323A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2420205A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/20/2003 | WO2003014128A2 Tumour inhibiting cerium compounds |
| 02/20/2003 | WO2003014088A1 Biphenyl thioamides serving as integrin receptor antagonists |
| 02/20/2003 | WO2003014087A1 Process for preparation of 5-methyl-1-phenyl-2(1h) -pyridinone |
| 02/20/2003 | WO2003014086A1 Process for the preparation of amorphous form of torsemide |
| 02/20/2003 | WO2003014062A1 Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents |
| 02/20/2003 | WO2003014061A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions |
| 02/20/2003 | WO2003013723A1 Palladium catalysts |
| 02/20/2003 | WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 02/20/2003 | WO2003013502A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2003013247A1 Pyridylpropynyloxyphenyl derivatives for use as herbicides |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002088323A3 Gene delivery compounds |
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002060874A8 Potassium channel inhibitors |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036656 Method for obtaining derivatives of [ [(pyridil substituted)methyl]thio]benzomidazol |
| 02/20/2003 | US20030036653 For prophylaxis and therapy of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and Kaposi herpesvirus |
| 02/20/2003 | US20030036615 Contacting ethylene with an iron complex of a selected 2,6-pyridinedicarboxaldehyde bisimine; products may be polymerized or converted into an alcohol |
| 02/20/2003 | US20030036532 Treatment of infections caused by parasites, especially malaria. |
| 02/20/2003 | DE20217957U1 Oxidative dyeing agent for keratin fibers uses 2-aminomethylene-substituted resorcinols as couplers, some of which are novel compounds |
| 02/20/2003 | CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | CA2456550A1 Tumour inhibiting cerium compounds |
| 02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | CA2453951A1 Pyridylpropynyloxyphenyl derivatives for use as herbicides |
| 02/19/2003 | EP1283844A1 Metallocenes as signal-transducer for detection of chemical or biological events |
| 02/19/2003 | EP1283830A1 Para-amine substituted phenylamide glucokinase activators |
| 02/19/2003 | EP1283828A1 Novel polymorph v of torasemide |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283711A1 Peptide deformylase inhibitors |
| 02/19/2003 | EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |